Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry

Trial Profile

Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs Glucagon like peptide 1 receptor agonists; Liraglutide
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 25 Jan 2012 New trial record
    • 24 Jan 2012 Actual start date added, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top